Viewing StudyNCT04601610



Ignite Creation Date: 2024-05-06 @ 3:21 PM
Last Modification Date: 2024-10-26 @ 1:47 PM
Study NCT ID: NCT04601610
Status: TERMINATED
Last Update Posted: 2022-10-28
First Post: 2020-10-19

Brief Title: KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co Ltd
Organization: Jiangsu Alphamab Biopharmaceuticals Co Ltd

Organization Data

Organization: Jiangsu Alphamab Biopharmaceuticals Co Ltd
Class: INDUSTRY
Study ID: KN046-208
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Jiangsu Alphamab Biopharmaceuticals Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Sunshine Lake Pharma Co Ltd INDUSTRY